Advertisement: Cambridge Network
ARM Innovation Hub
Advertisement EY mid banner
Advertisement: Simpsons Creative
Advertisement: Wild Knight Vodka
Barr Ellison Solicitors – commercial property
Advertisement: Mogrify
Mid banner advertisement: BDO
Advertisement: RSM
Advertisement: EBCam mid banner
RealVNC mid-banner general
RealVNC mid banner careers
Advertisement: TTP
14 February, 2020 - 20:59 By Kate Sweeney

Laboratory space take-up rockets in Cambridge

Take-up of laboratory space in Cambridge was 10 times higher in 2019, jumping from 17,145 sq ft in 2018 to more than 214,100 sq ft. This equates to 29 pr cent of all commercial property transactions over the past 12 months, according to Savills research.

Key deals in 2019 included RxCelerate UK occupying 25,000 sq ft at the Babraham Research Campus, which saw 79,000 sq ft of space let in total last year. Lonza and Microbiotica took 41,325 sq ft and 18,894 sq ft, respectively, at Chesterford Research Park.

Savills notes that demand for lab-fitted product has skyrocketed as firms look to take advantage of ready to occupy space within Cambridge’s world-class science and innovation clusters. 

As a result, Savills figures show that supply of laboratory, office and R & D space fell to just over six per cent by the end of Q4 2019, down from more than eight per cent at the start of the year.

Across the UK the level of capital raised by UK headquartered life science companies (including M & A, IPO and venture capital transactions) hit £27.6 billion in 2019, a 135 per cent increase on 2018. 

Savills anticipates that this significant growth of activity in the sector will lead to an uptick in real estate requirements from occupiers looking for this kind of space.

Off the back of the success of the life science and pharmaceutical sectors, the Cambridge office market, as a whole, had a very strong year. Overall take-up in the city reached 737,000 sq ft in 2019, 47 per cent above the long term average.

William Clarke, director in the business space team at Savills Cambridge, said: “Where previously we have seen occupiers take the build-to-suit option when it comes to laboratory space, we are now seeing a surge in requirements for existing fitted product, especially as firms look to upscale on a reactive basis. 

“Consequently, developers are having to factor this in when starting new schemes across the city. Cambridge has always had a reputation as a key UK tech and life science innovation hub so it is crucial that we cater for the unique demands of these types of businesses in order to further enhance the reputation of the region.”

Newsletter Subscription

Stay informed of the latest news and features